Allison Kendall, Julie K Byron, Jodi L Westropp, Joan R Coates, Shelly Vaden, Chris Adin, Garrett Oetelaar, Joe W Bartges, Jonathan D Foster, Larry G Adams, Natasha Olby, Allyson Berent
5 min
Urinary incontinence (UI) is a common disorder of micturition in dogs, with an estimated prevalence of 3% to 20% in spayed females, while male cases are less understood. Normal lower urinary tract function relies on a coordinated balance between the storage and voiding phases, managed by autonomic and somatic spinal cord pathways alongside supraspinal input from the brain. The bladder serves as a compliant reservoir regulated by sympathetic relaxation and parasympathetic contraction, whereas the urethra functions as a high-pressure sphincter sustained by smooth and striated muscle components and somatic innervation via the pudendal nerve.
The consensus panel emphasizes that canine UI should be divided into two primary categories: disorders of storage and disorders of voiding. Storage disorders involve involuntary leakage with a normal postvoiding residual volume, and they are further subdivided into functional causes—such as urethral sphincter mechanism incompetence (USMI)—and mechanical causes like ectopic ureters. Conversely, voiding disorders present with a high postvoiding residual volume due to either functional outflow obstruction or mechanical obstruction. Female dogs are disproportionately affected by storage disorders, whereas males experience a more even distribution of storage and voiding dysfunctions.
The diagnostic process begins with a meticulous clinical history and direct observation of the dog's voiding behaviors to establish pattern recognition. For female dogs, specific leakage contexts—such as leaking at rest in USMI versus continuous dripping from juvenile ectopic ureters—often point toward a presumptive diagnosis. In contrast, pattern recognition is less straightforward in male dogs due to anatomical differences, requiring careful evaluation of urine streams, posturing, and postvoid residual volumes to differentiate between functional and mechanical outflow obstructions.
Management strategies must be tailored to the specific underlying pathophysiology identified through diagnostic workups, ranging from medical management with hormone therapy or alpha-adrenergic agonists for USMI to surgical or interventional procedures for anatomical anomalies. Because direct comparative prospective clinical trials remain scarce in veterinary medicine, this consensus framework provides essential clinical guidance to help practitioners navigate complex diagnostic algorithms and select targeted therapies for canine patients.
Urinary incontinence (UI) is a disorder of micturition that can occur in dogs of any age, sex, and breed depending on the underlying cause and time of onset. Diagnosis and treatment for various causes of UI in dogs have been described by multiple comprehensive single author review articles, but large prospective clinical trials comparing treatment outcomes in veterinary medicine are lacking. The objectives of this consensus statement therefore are to provide guidelines on both recommended diagnostic testing and treatment for various causes of UI in dogs. Specifically, pathophysiology directly related to the canine urinary system will be reviewed and diagnostic and therapeutic challenges will be addressed. A panel of 12 experts in the field (8 small animal internists [L. Adams, J. Bartges, A. Berent, J. Byron, J. Foster, A. Kendall, S. Vaden, J. Westropp], 2 neurologists [J. Coates, N. Olby], 1 radiologist [G. Oetelaar], and 1 surgeon [C. Adin]) was formed to assess and summarize evidence in the peer-reviewed literature and to complement it with consensus recommendations using the Delphi method. Some statements were not voted on by all panelists. This consensus statement aims to provide guidance for management of both male and female dogs with underlying storage or voiding disorders resulting in UI.
Alex: And how do they correct something like that without major surgery?
Sam: Through the same endoscope, they can pass a tiny laser to cut a new opening so the tube connects to the bladder where it should. It's a precise, minimally invasive fix. They also look for mineral deposits or physical blockages that might be preventing urine from flowing out normally.
Alex: What if imaging still doesn't give a clear answer?
Sam: Then they can measure pressures and flow rates directly using specialized sensors — a process called urodynamics. Think of it like putting a pressure gauge on the plumbing. It maps out exactly how the bladder muscle and the urethral valve are coordinating, or failing to coordinate, during both the filling and emptying phases.
Alex: That sounds like it could be genuinely revealing. Are there limitations to it?
Sam: There are. The authors are candid about this. Urodynamic testing and some of the imaging techniques aren't widely available, and they require the animal to be under anaesthesia — which itself changes how the muscles behave. So the measurements are taken under conditions that don't perfectly reflect normal, conscious function.
Alex: So even the diagnostic tools have built-in uncertainty.
Sam: They do. And the paper acknowledges that well-designed clinical trials with standardized outcome measures are still needed to pin down the best drug doses and directly compare treatments. Much of the current guidance rests on expert consensus rather than large controlled studies.
Alex: That's an honest picture of where the field stands. What does the paper see as the path forward?
Sam: The core message is a shift away from trial-and-error and toward structured, targeted workflows — categorize the problem accurately first, then choose the intervention. For structural issues like malformations or blockages, timely procedures such as laser correction or stent placement are recommended, though they require specialist expertise to avoid complications.
Alex: And looking further ahead?
Sam: The authors point toward automated home monitoring systems that could track voiding patterns and flag problems before clinical symptoms even appear — catching issues earlier, when they're easier to manage.
Alex: It's a field that's clearly moving toward more precision, even if the evidence base is still catching up. Thanks for listening to ResearchPod.